Goldman Sachs Group Inc Ngm Biopharmaceuticals Inc Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.17 - $1.92 $115,380 - $189,342	98,616 Added 89.1%	209,298 $332,000
Q4 2023 Feb 13, 2024	SELL	$0.6 - $1.31 $97,607 - $213,109	-162,679 Reduced 59.51%	110,682 $95,000
Q3 2023 May 14, 2024	BUY	$1.05 - $3.37 $170,812 - $548,228	162,679 Added 146.98%	273,361 $292,000
Q3 2023 Nov 14, 2023	BUY	$1.05 - $3.37 $38,456 - $123,426	36,625 Added 15.47%	273,361 $292,000
Q2 2023 May 14, 2024	BUY	$2.44 - $4.53 $112,076 - $208,076	45,933 Added 24.07%	236,736 $613,000
Q2 2023 Aug 14, 2023	BUY	$2.44 - $4.53 $112,076 - $208,076	45,933 Added 24.07%	236,736 $613,000
Q1 2023 May 14, 2024	SELL	$3.72 - $5.4 $702,540 - $1.02 Million	-188,855 Reduced 49.74%	190,803 $778,000
Q1 2023 May 11, 2023	SELL	$3.72 - $5.4 $702,540 - $1.02 Million	-188,855 Reduced 49.74%	190,803 $778,000
Q4 2022 May 14, 2024	BUY	$3.41 - $12.93 $156,924 - $595,025	46,019 Added 13.79%	379,658 $1.91 Million
Q4 2022 Feb 13, 2023	BUY	$3.41 - $12.93 $156,924 - $595,025	46,019 Added 13.79%	379,658 $1.91 Million
Q3 2022 May 14, 2024	BUY	$12.59 - $17.67 $2.03 Million - $2.85 Million	161,433 Added 93.74%	333,639 $4.36 Million
Q3 2022 Nov 10, 2022	BUY	$12.59 - $17.67 $2.03 Million - $2.85 Million	161,433 Added 93.74%	333,639 $4.36 Million
Q2 2022 May 14, 2024	BUY	$10.58 - $17.5 $650,923 - $1.08 Million	61,524 Added 55.59%	172,206 $2.21 Million
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $87,687 - $145,040	8,288 Added 5.06%	172,206 $2.21 Million
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $592,393 - $797,865	-42,896 Reduced 20.74%	163,918 $2.5 Million
Q4 2021 Feb 14, 2022	SELL	$17.26 - $22.02 $771,021 - $983,655	-44,671 Reduced 17.76%	206,814 $3.66 Million
Q3 2021 Nov 10, 2021	BUY	$20.15 - $26.19 $5.07 Million - $6.59 Million	251,485 New	251,485 $5.29 Million

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account